Skip to main content

Table 1 Demographic characteristics of children with VEOIBD with IL10R deficiency

From: Complications of enterostomy and related risk factor analysis of very early onset inflammatory bowel disease with interleukin-10 signalling deficiency: a single-centre retrospective analysis

Characteristic

 Male: n (%)

14(63.6%)

 Age at diagnosis (m): median [IQR]

9(3.5,21.5)

 Duration of follow-up (m): median [IQR]

16.0(4.8,31.3)

 Diarrhoea: n (%)

21(94.5)

 Fever: n (%)

11(50.0%)

 Oral ulcer: n (%)

7(31.8%)

 Perianal disease: n (%)

16(72.7%)

Growth parameters at first hospitalization

 Weight-for-age Z-score: median [IQR]

−3.5(−4.7, −2.7)

 Height-for-age Z-score: median [IQR]

−3.1(− 4.7, − 2.2)

 BMI Z-score: median [IQR]

−2.6(− 3.8, − 0.53)

Medication usage prior to enterostomy

 Thalidomide: n (%)

17(77.3%)

 HSCT: n (%)

10(45.5%)

 Mesalazine: n (%)

10(45.5%)

 Infliximab: n (%)

3(13.6%)